Biologic and Immunologic Effects of Preoperative Trastuzumab for Ductal Carcinoma in Situ of the Breast

PURPOSE: To investigate the biologic and immunologic effects of preoperative trastuzumab in patients with ductal carcinoma in situ (DCIS) of the breast. EXPERIMENTAL DESIGN: Patients with DCIS were enrolled on this open-label phase II trial and tested for HER2. Trastuzumab was by intravenous infusio...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kuerer, Henry M., Buzdar, Aman U., Mittendorf, Elizabeth A., Esteva, Francisco J., Lucci, Anthony, Vence, Luis M., Radvanyi, Laszlo, Meric-Bernstam, Funda, Hunt, Kelly K., Symmans, W. Fraser
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2997136/
https://ncbi.nlm.nih.gov/pubmed/20740500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25399
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires